Brief: HBM Holdings Commenced Collaborations On Antibody-Drug Conjugate Projects
30/05/2022 15:02
May 30 (Reuters) - LegoChem Biosciences Inc 141080.KQ :
* COMMENCED COLLABORATIONS ON ANTIBODY-DRUG CONJUGATE
PROJECTS
WITH LEGOCHEM BIOSCIENCES AND DUALITY BIOTHERAPEUTICS
Further company coverage: 141080.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study